These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35362024)

  • 1. SARS-CoV-2 infection markedly increases long-term cardiovascular risk.
    Liuzzo G; Volpe M
    Eur Heart J; 2022 May; 43(20):1899-1900. PubMed ID: 35362024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.
    Filipiak-Strzecka D; Plewka M; Szymczyk E; Frynas-Jończyk K; Szymczyk K; Lipiec P; Kasprzak JD
    Cardiol J; 2022; 29(5):878-879. PubMed ID: 36196658
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19.
    Parums DV
    Med Sci Monit; 2022 May; 28():e937048. PubMed ID: 35490309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID‑19 pandemic on blood pressure control and cardiovascular risk profile in patients with hypertension.
    Januszewicz A; Wojciechowska W; Prejbisz A; Dobrowolski P; Rajzer M; Kreutz R
    Pol Arch Intern Med; 2021 Oct; 131(10):. PubMed ID: 34704702
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    Abbasi J
    JAMA; 2022 Mar; 327(12):1113-1114. PubMed ID: 35234824
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Siniorakis E; Arvanitakis S; Katsianis A; Nikolopoulos I
    J Korean Med Sci; 2021 Apr; 36(15):e113. PubMed ID: 33876590
    [No Abstract]   [Full Text] [Related]  

  • 7. [COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].
    Pallarés-Carratalá V; Polo García J; Martín Rioboo E; Ruíz García A; Serrano-Cumplido A; Barrios V;
    Semergen; 2021; 47(1):1-3. PubMed ID: 33478841
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation.
    Antza C; Stabouli S
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1947-1948. PubMed ID: 32882108
    [No Abstract]   [Full Text] [Related]  

  • 9. The COVID-19 pandemic: lifestyle and cardiovascular risk factors.
    Bhatnagar D
    Curr Opin Lipidol; 2021 Feb; 32(1):71-73. PubMed ID: 33315619
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 and cardiovascular risk: Flying toward a silent world?
    Dutheil F; Baker JS; Navel V
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1945-1946. PubMed ID: 32892458
    [No Abstract]   [Full Text] [Related]  

  • 11. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telemedicine in Cardiology for Outpatient Follow-Up of Patients at High Cardiovascular Risk in Response to the COVID-19 Pandemic.
    Moreira HT; Volpe GJ; Rezek UC; Mendonça PC; Teixeira GCA; Santos BMD; Olivieri APG; Chierice AJA; Monteiro HZ; Araújo NM; Maciel BC; Pazin Filho A; Schmidt A
    Arq Bras Cardiol; 2021 Jan; 116(1):153-157. PubMed ID: 33566981
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial commentary: COVID-19 as a cardiovascular disease risk factor.
    Oktay AA; Suboc TM; Volgman AS
    Trends Cardiovasc Med; 2022 Nov; 32(8):476-478. PubMed ID: 35850405
    [No Abstract]   [Full Text] [Related]  

  • 14. Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.
    Otto CM
    Heart; 2021 Mar; 107(5):345-347. PubMed ID: 33574131
    [No Abstract]   [Full Text] [Related]  

  • 15. Large Increases in the Risk of Cardiovascular Events Following COVID-19 Infection That Required Hospitalization.
    Ebell MH
    Am Fam Physician; 2022 Aug; 106(2):Online. PubMed ID: 35977122
    [No Abstract]   [Full Text] [Related]  

  • 16. Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children.
    Zhang Y; Wang L; Wei S
    Braz J Cardiovasc Surg; 2021 Oct; 36(5):685-690. PubMed ID: 33355798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Cardiac and Cardiovascular Effects of COVID-19 in Adults and Children.
    Das BB; Sexon Tejtel SK; Deshpande S; Shekerdemian LS
    Tex Heart Inst J; 2021 Jul; 48(3):. PubMed ID: 34340244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors.
    Podestà MA; Valli F; Galassi A; Cassia MA; Ciceri P; Barbieri L; Carugo S; Cozzolino M
    Blood Purif; 2021; 50(6):740-749. PubMed ID: 33752209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
    Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges.
    Shah KS; Hale Hammond ME; Drakos SG; Anderson JL; Fang JC; Knowlton KU; Shaw RM
    Future Cardiol; 2021 Oct; 17(7):1277-1291. PubMed ID: 33739142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.